Obesity influences the outcomes of anti‐IgE (omalizumab) therapy of asthma
Chao Gu, Katherine Upchurch, James Mamaril‐Davis, Matthew Wiest, Bobby Q. Lanier, Mark Millard, Jacob Turner, HyeMee Joo, SangKon Oh
Abstract
The authors declare no conflicts of interest. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
OmalizumabAsthmaImmunoglobulin EMedicineImmunologyIntensive care medicineAntibodyAsthma and respiratory diseasesIL-33, ST2, and ILC PathwaysEosinophilic Esophagitis